Mirion Technologies, Inc. has recently released its 10-Q report, providing a detailed look into the company's financial performance and operations. Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis, and monitoring products and services. The company operates through two segments, Medical and Technologies, offering a wide range of products and solutions for various industries including medical, nuclear, defense, laboratories, and scientific research.
In the 10-Q report, Mirion Technologies, Inc. reported revenues of $207.1 million for the three months ended June 30, 2024, and $399.7 million for the six months ended June 30, 2024. The Medical segment contributed 35.3% of the revenues for the three months ended June 30, 2024, and 35.0% for the six months ended June 30, 2024. The Technologies segment generated 64.7% and 65.0% of the revenues for the three and six months ended June 30, 2024, respectively. The company's backlog, representing committed but undelivered contracts and purchase orders, was $824.7 million as of June 30, 2024.
Mirion Technologies, Inc. highlighted several key factors that may impact its performance, including international conflicts, inflation, interest rates, tariffs or sanctions, medical end market trends, strategic transactions, environmental objectives of governments, government budgets, nuclear new build projects, research and development, financial risks, and global risks.
The company also provided non-GAAP financial measures, including EBITA, EBITDA, and Adjusted EBITDA, for the three and six months ended June 30, 2024, and June 30, 2023. These measures offer additional meaningful information for assessing the company's ongoing performance and are used by management in making financial, operating, and planning decisions.
Following these announcements, the company's shares moved -2.0%, and are now trading at a price of $10.09. If you want to know more, read the company's complete 10-Q report here.
